Universitätsklinikum Heidelberg

Recruitment of the multiple sclerosis cohort within the European Mobilise-D clinical validation study—lessons learnt, baseline demographics and clinical characteristics (2026) Brittain G, Buckley E, Lanfranchi V, Long M, Tsaktanis T, Rothhammer V, Hansen C, et al. Journal article Smelling the romantic partner’s natural body odor increases psychological and autonomic but not cortisol stress responses (2026) Spengler FB, Doerflinger JT, Noel JA, Ditzen B, Freiherr J, Heinrichs M Journal article Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma (2026) Kaulen LD, Karschnia P, Doubrovinskaia S, Abramson JS, Soumerai JD, Martinez-Lage M, Haydu JE, et al. Journal article Transcriptomic response of human mesenchymal stromal cells exposed to Boron- and Molybdenum-substituted mesoporous bioactive glass nanoparticles (2026) Kunisch E, Nawaz Q, Walker T, Renkawitz T, Boccaccini AR, Westhauser F Journal article A longitudinal bifactor approach to modelling somatic symptom development in psychosomatic treatment (2026) Petzke TM, Köteles F, Kessler H, Doering S, Kehyayan A, Pape M, Hofmann T, et al. Journal article Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis (2026) Wurschi GW, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, Diefenhardt M, et al. Journal article De-escalation strategies in the treatment of oral squamous cell carcinoma: A cross-sectional study in oral and maxillofacial surgery in Germany, Austria, and Switzerland (2026) Becker P, Raguse JD, Rau A, Wermker K, Beck-Broichsitter B, Weber M, Bouffleur F, et al. Journal article Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial (2026) Hörner M, Tretschock LM, John N, Ziegler P, Häberle L, Uhrig S, Goossens C, et al. Journal article Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging Features (2026) Müller KJ, Karschnia P, Kaulen LD, Reis J, Gakis G, Englert B, Hinz F, et al. Journal article Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma (2026) Dummer R, Sandhu S, Miller WH, Butler MO, Taylor MH, Heinzerling L, Blank CU, et al. Journal article